Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 13 May

Sophia Mavridis
May 13, 2022

Morning Bell 12 May

Paulina Peters
May 12, 2022

Morning Bell 11 May

Sophia Mavridis
May 11, 2022

Morning Bell 10 May

Paulina Peters
May 10, 2022

Morning Bell 9 May

Sophia Mavridis
May 9, 2022

Weekly Wrap 6 May

Sophia Mavridis
May 6, 2022

Morning Bell 5 May

Paulina Peters
May 5, 2022

Morning Bell 4 May

Sophia Mavridis
May 4, 2022

Morning Bell 3 May

Paulina Peters
May 3, 2022

Morning Bell 2 May

Sophia Mavridis
May 2, 2022

Weekly Wrap 29 April

Sophia Mavridis
April 29, 2022

Morning Bell 28 April

Paulina Peters
April 28, 2022